| Top 5 Stories : |
|
Obama's Mixed Message for Biopharma R&D
President Obama took center stage last week to unveil his "Precision Medicine Initiative," a $215 million program to build a massive database of patient genomic information to support future biomedical research.
Read more
|
|
| |
Sponsored
learn more about how to leverage Data and Analytics to enhance Copay Program Performance with this White Paper and Case Study.
 Read more
|
| |
|
|
|
Why Alliances Fail
Most biotech-pharma alliances fall short of expectations. But are they doomed -- or just difficult? In this second of two parts, experts say strategic partnerships offer acceptable odds, but only if you know what you're doing.
Read more
|
|
|
2015 Pipeline Report: Burning Bright
Tracking new therapies as they wind their way through development, regulatory approval, and payer acceptance can be like waiting for paint to dry and then repainting in a different color. It's a slow process and far from linear.
Read more
|
|
|
|
